Match tier Listed
Presence Current · Arkansas
Last published 2025
Sources OpenAlex · ORCID
Refreshed 2026-08-08

Logan Meurer

Researcher

Graduate Student Researcher

1 h-index 1 pubs 3 cited

  • Anesthetics, Local
  • Antidotes
  • Bupivacaine
  • Fat Emulsions, Intravenous
  • Plasma Exchange
  • Hypertriglyceridemia
  • Adult
  • Female
  • Humans
  • Male
  • Triglycerides

Biography and Research Information

OverviewAI-generated summary

Logan Meurer's research centers on the management of local anesthetic systemic toxicity (LAST), with a specific focus on the use of intravenous lipid emulsions as an antidote. Meurer has investigated the potential complications associated with this treatment, including an instance where the antidote may have exacerbated the patient's condition. This led to the study of emergent therapeutic plasma exchange as a subsequent intervention. Collaborating with Gina Drobena, P Ravikumar, and Brooke Yasgur at the University of Arkansas for Medical Sciences, Meurer's work contributes to understanding critical care interventions for LAST.

Metrics

  • h-index: 1
  • Publications: 1
  • Citations: 3

Selected Publications

  • New-Onset Sarcoidosis During B-cell Maturation Antigen (BCMA)-Directed T-cell Engager Therapy With Teclistamab in Relapsed/Refractory High-Risk Multiple Myeloma: A Case Report and Mechanistic Insight (2026)
    Cureus DOI OpenAlex
  • Antidote Worse Than the Poison? Emergent Therapeutic Plasma Exchange After Overzealous Intravenous Lipid Emulsion Infusion During Treatment of Local Anesthetic Systemic Toxicity (2025)
    Journal of Clinical Apheresis 3 citations DOI OpenAlex

View all publications on OpenAlex →

Collaboration Network

4 Collaborators 1 Institution 1 Country

Top Collaborators

View profile →
View profile →
View profile →
View profile →

Similar Researchers

Based on overlapping research topics